Phenotypic expression and prevalence of ESBL-producing Enterobacteriaceae in samples collected from patients in various wards of Mulago Hospital, Uganda

BMC Clinical Pharmacology

James G Ndukui¹  Musisi Nathan Lubowa¹  Collins Atuhaire¹  Ronah Kantume¹  John N Kateregga¹ 

[1] College of Veterinary Medicine, Animal Resources & Biosecurity, Makerere University, Kampala, Uganda

关键词: Clavulanic acid;    Ceftazidime;    Cefotaxime;    Enterobacteriaceae;    ESBL;   

Others  :  1210273
DOI  :  10.1186/s40360-015-0013-1

 received in 2014-12-23, accepted in 2015-05-20,  发布年份 2015

【 摘 要 】

Background

Resistance to extended-spectrum cephalosporins among Enterobacteriaceae has been reported yet they serve as the last line treatment for severe infections in Uganda and other countries. This resistance often leads to nosocomial infection outbreaks and therapeutic failures from multidrug resistant bacteria. The main objective of this study was to determine the prevalence of extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae in clinical samples of patients in various wards of Mulago Hospital; Uganda’s main national referral and teaching hospital.

Methods

This cross-sectional study was conducted between January-April, 2014. Purposive consecutive sampling was used to collect pus swab, urine, blood and CSF samples from patients in the various wards. A total of 245 consecutive, non-repetitive, clinical samples were obtained and tested for phenotypic ESBL production using the Double Disc Synergy Test using cefotaxime, ceftazidime, cefotaxime-clavulanic acid and ceftazidime-clavulanic acid.

Results

Results show that 47 % of the 245 samples had Enterobacteriaceae isolates. Of these isolates 62 % were ESBL producers while 38 % were of non-ESBL phenotype. E. coli was the most isolated organism (53.9 %), followed by K. pneumoniae (28.7 %). Majority of Enterobacteriaceae organisms were isolated from urine samples, followed by pus samples and of these 64.9 % and 47.4 % were ESBL-producers respectively. Klebsiella pneumoniae had the highest percentage of ESBL producers (72.7 %). There was a higher percentage of isolates showing resistance to ceftazidime (73 %) compared to cefotaxime (57.5 %). All Enterobacter cloacae isolates showed resistance to ceftazidime. There were no statistically significant association between phenotype (ESBL/non-ESBL) and patients’ age or gender or Enterobacteriaceae spp.

Conclusions

This study reveals a high prevalence of ESBL producing organisms in Mulago Hospital and high levels of resistance to third generation cephalosporins. In addition to undertaking appropriate infection control measures, there is urgent need for formulation of an antibiotic policy in Uganda to prevent spread of these organisms. This also calls for continuous monitoring and reporting of the presence of such organisms in order to ensure rational and judicious use of antibiotics by clinicians.

【 授权许可】

   
2015 Kateregga et al.

【 图 表 】

Fig. 1.

Fig. 2.

【 参考文献 】

• [1]Toth A, Juhasz-Kaszanyitzky E, Mag T, Hajbel-Vekony G, Paszti J, Damjanova I. Characterization of extended-spectrum beta-lactamase (ESBL) producing Escherichia coli strains isolated from animal and human clinical samples in Hungary in 2006–2007. Acta Microbiol Immunol Hung. 2013; 60:175-85.
• [2]Hoban DJ, Lascols C, Nicolle LE, Badal R, Bouchillon S, Hackel M, Hawser S. Antimicrobial susceptibility of Enterobacteriaceae, including molecular characterization of extended-spectrum beta-lactamase-producing species, in urinary tract isolates from hospitalized patients in North America and Europe: results from the SMART study 2009–2010. Diag Microbiol Infect Dis. 2012; 74:62-7.
• [3]Akindele JA, Rotilu IO. Outbreak of neonatal Klebsiella septicaemia: a review of antimicrobial sensitivities. Afr J Med Med Sci. 1997; 26:51-53.
• [4]Musoke RN, Revathi G. Emergence of multidrug-resistant gram-negative organisms in a neonatal unit and the therapeutic implications. J Trop Pediatr. 2000; 46:86-91.
• [5]Dayan NH, Dabbah I, Weissman I, Aga I, Even L, Glikman D. Urinary Tract Infections Caused by Community-Acquired Extended-Spectrum beta-Lactamase-Producing and Nonproducing Bacteria: A Comparative Study. J Pediatr. 2013; 163:1417-21.
• [6]Badal RE, Bouchillon SK, Lob SH, Hackel MA, Hawser S, Hoban DJ. Etiology, Extended-Spectrum Beta-Lactamase Rates and Antimicrobial Susceptibility of Gram-negative Bacilli causing Intra-abdominal Infections in Patients in General Pediatric and Pediatric Intensive Care Units - Global Data from the Study for Monitoring Antimicrobial Resistance Trends 2008–2010. Pediatr Infect Dis J. 2013; 32:636-40.
• [7]Agostinho A, Renzi G, Haustein T, Jourdan G, Bonfillon C, Rougemont M, Hoffmeyer P, Harbarth S, Uckay I. Epidemiology and acquisition of extended-spectrum beta-lactamase-producing in a septic orthopedic ward. Springerplus. 2013; 2:91. BioMed Central Full Text
• [8]Kish L. Sampling Organizations and Groups of Unequal Sizes. Am Sociol Rev. 1965; 30:564-72.
• [9]Seni J, Najjuka CF, Kateete DP, Makobore P, Joloba ML, Kajumbula H, Kapesa A, Bwanga F. Antimicrobial resistance in hospitalized surgical patients: a silently emerging public health concern in Uganda. BMC Research Notes. 2013; 6:298. BioMed Central Full Text
• [10]Cheesebrough M: [District Laboratory Practice in Tropical Countries Part II]. Second Edition, Cambridge University Press 2006. p. 62. http://www.cambridge.org/us/academic/subjects/medicine/medicine-general-interest/district-laboratorypractice-tropical-countries-part-2-2nd-edition.
• [11]Performance Standards for Antimicrobial Susceptibility Testing: Twentieth Informational Supplement M100-S20. CLSI, Wayne, PA, USA; 2010.
• [12]Trivedi M, Patel V, Soman R, Rodriguez C, Singhal T. The Outcome of Treating ESBL Infections with Carbapenems vs. Non Carbapenem Antimicrobials. J Assoc Physicians India. 2012; 60:28-30.
• [13]Kiratisin P, Apisarnthanarak A, Laesripa C, Saifon P. Molecular characterization and epidemiology of extended spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care associated infection in Thailand, where the CTX-M family is endemic. Antimicrob Agents Chemother. 2008; 52:2818-2824.
• [14]Wilson ML, Gaido L. Laboratory diagnosis of urinary tract infections in adult patients. Clinical Infectious Diseases. 2004; 38:1150-1158.
• [15]Moyo SJ, Aboud S, Kasubi M, Lyamuya EF, Maselle SY. Antimicrobial resistance among producers and non-producers of extended spectrum beta-lactamases in urinary isolates at a tertiary Hospital in Tanzania. BMC Research Notes. 2010; 3:348. BioMed Central Full Text
• [16]Maina D, Revathi G, Kariuki S, Ozwara H. Genotypes and cephalosporin susceptibility in extended-spectrum β-lactamase producing enterobacteriaceae in the community. The Journal of Infection in Developing Countries. 2011; 6:470-477.
• [17]Bindayna KM, Senok AC, Jamsheer AE. Prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Bahrain. Journal of Infection and Public Health. 2009; 2:129-135.